Two decades ago, the sequence of the first human genome was published. Since then, advances in genome technologies have resulted in whole-genome sequencing and microarray-based genotyping of millions of human genomes. However, genetic and genomic studies are predominantly based on populations of European ancestry. As a result, the potential benefits of genomic research—including better understanding of disease etiology, early detection and diagnosis, rational drug design and improved clinical care—may elude the many underrepresented populations. Here, we describe factors that have contributed to the imbalance in representation of different populations and, leveraging our experiences in setting up genomic studies in diverse global populations, we propose a roadmap to enhancing inclusion and ensuring equal health benefits of genomics advances. Our Perspective highlights the importance of sincere, concerted global efforts toward genomic equity to ensure the benefits of genomic medicine are accessible to all.
This is a preview of subscription content
Subscribe to Nature+
Get immediate online access to the entire Nature family of 50+ journals
Subscribe to Journal
Get full journal access for 1 year
only $4.92 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Get time limited or full article access on ReadCube.
All prices are NET prices.
Buniello, A. et al. The NHGRI-EBI GWAS Catalog of published genome-wide association studies, targeted arrays and summary statistics 2019. Nucleic Acids Res. 47, D1005–D1012 (2019).
Patin, E. et al. Dispersals and genetic adaptation of Bantu-speaking populations in Africa and North America. Science 356, 543–546 (2017).
Auton, A. & Salcedo, T. in Assessing Rare Variation in Complex Traits: Design and Analysis of Genetic Studies (eds Zeggini, E. & Morris, A.) 71–85 (Springer New York, 2015).
Fan, S., Hansen, M. E. B., Lo, Y. & Tishkoff, S. A. Going global by adapting local: a review of recent human adaptation. Science 354, 54–59 (2016).
Majara, L. et al. Low generalizability of polygenic scores in African populations due to genetic and environmental diversity. Preprint at bioRxiv https://doi.org/10.1101/2021.01.12.426453 (2021).
Huang, Q. Q. et al. Transferability of genetic loci and polygenic scores for cardiometabolic traits in British Pakistanis and Bangladeshis. Preprint at https://www.medrxiv.org/content/10.1101/2021.06.22.21259323v1 (2021).
Sirugo, G., Williams, S. M. & Tishkoff, S. A. The missing diversity in human genetic studies. Cell 177, 26–31 (2019).
Asimit, J. L., Hatzikotoulas, K., McCarthy, M., Morris, A. P. & Zeggini, E. Trans-ethnic study design approaches for fine-mapping. Eur. J. Hum. Genet. 24, 1330–1336 (2016).
Chikowore, T. et al. Polygenic prediction of type 2 diabetes in continental Africa. Preprint at bioRxiv https://doi.org/10.1101/2021.02.11.430719 (2021).
Inouye, M. et al. Genomic risk prediction of coronary artery disease in 480,000 adults: implications for primary prevention. J. Am. Coll. Cardiol. 72, 1883–1893 (2018).
Fatumo, S. The opportunity in African genome resource for precision medicine. EBioMedicine 54, 102721 (2020).
Fatumo, S. et al. Discovery and fine-mapping of kidney function loci in first genome-wide association study in Africans. Hum. Mol. Genet. 30, 1559–1568 (2021).
Karczewski, K. J. et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature 581, 434–443 (2020).
Genovese, G. et al. A risk allele for focal segmental glomerulosclerosis in African Americans is located within a region containing APOL1 and MYH9. Kidney Int. 78, 698–704 (2010).
Rotimi, C. N. et al. The genomic landscape of African populations in health and disease. Hum. Mol. Genet. 26, R225–R236 (2017).
Cohen, J. et al. Low LDL cholesterol in individuals of African descent resulting from frequent nonsense mutations in PCSK9. Nat. Genet. 37, 161–165 (2005).
Gao, C. et al. Risk of breast cancer among carriers of pathogenic variants in breast cancer predisposition genes varies by polygenic risk score. J. Clin. Oncol. 39, 2564–2573 (2021).
Torkamani, A., Wineinger, N. E. & Topol, E. J. The personal and clinical utility of polygenic risk scores. Nat. Rev. Genet. 19, 581–590 (2018).
Martin, A. R. et al. Human demographic history impacts genetic risk prediction across diverse populations. Am. J. Hum. Genet. 100, 635–649 (2017).
Scutari, M., Mackay, I. & Balding, D. Using genetic distance to infer the accuracy of genomic prediction. PLoS Genet. 12, e1006288 (2016).
Martin, A. R. et al. Clinical use of current polygenic risk scores may exacerbate health disparities. Nat. Genet. 51, 584–591 (2019).
Sengupta, D., Choudhury, A., Basu, A. & Ramsay, M. Population stratification and underrepresentation of indian subcontinent genetic diversity in the 1000 genomes project dataset. Genome Biol. Evol. 8, 3460–3470 (2016).
Oh, S. S. et al. Diversity in clinical and biomedical research: a promise yet to be fulfilled. PLoS Med. 12, e1001918 (2015).
Bentley, A. R., Callier, S. & Rotimi, C. N. Diversity and inclusion in genomic research: why the uneven progress? J. Community Genet. 8, 255–266 (2017).
H3Africa Consortium et al. Research capacity. Enabling the genomic revolution in Africa. Science 344, 1346–1348 (2014).
Tindana, P. et al. Community engagement strategies for genomic studies in Africa: a review of the literature. BMC Med. Ethics 16, 24 (2015).
Hindorff, L. A. et al. Prioritizing diversity in human genomics research. Nat. Rev. Genet. 19, 175–185 (2018).
Tan, S.-H., Petrovics, G. & Srivastava, S. Prostate cancer genomics: recent advances and the prevailing underrepresentation from racial and ethnic minorities. Int. J. Mol. Sci. 19, E1255 (2018).
Reverby, S. M. Ethical failures and history lessons: the US Public Health Service Research Studies in Tuskegee and Guatemala. Public Health Rev. 34, 1–18 (2012).
Löwy, I. The best possible intentions testing prophylactic approaches on humans in developing countries. Am. J. Public Health 103, 226–237 (2013).
Kraft, S. A. et al. Beyond consent: building trusting relationships with diverse populations in precision medicine research. Am. J. Bioeth. 18, 3–20 (2018).
Global Forum for Health Research. The 10/90 Report on Health Research 2000 (http://www.globalforumhealth.org/).
McGregor, S., Henderson, K. J. & Kaldor, J. M. How are health research priorities set in low- and middle-income countries? A systematic review of published reports. PLoS ONE 9, e108787 (2014).
Sridhar, D. Who sets the global health research agenda? The challenge of multi-bi financing. PLoS Med. 9, e1001312 (2012).
Mbaye, R. et al. Who is telling the story? A systematic review of authorship for infectious disease research conducted in Africa, 1980–2016. BMJ Glob. Health 4, e001855 (2019).
Stein, C. M. Challenges of genetic data sharing in african studies. Trends Genet. 36, 895–896 (2020).
Wright, G. E. B., Koornhof, P. G. J., Adeyemo, A. A. & Tiffin, N. Ethical and legal implications of whole-genome and whole-exome sequencing in African populations. BMC Med. Ethics 14, 21 (2013).
Ascencio-Carbajal, T., Saruwatari-Zavala, G., Navarro-Garcia, F. & Frixione, E. Genetic/genomic testing: defining the parameters for ethical, legal and social implications. BMC Med. Ethics 22, 156 (2021).
Choudhury, A. et al. Whole-genome sequencing for an enhanced understanding of genetic variation among South Africans. Nat. Commun. 8, 2062 (2017).
The Malaria Genomic Epidemiology Network. A global network for investigating the genomic epidemiology of malaria. Nature 456, 732–737 (2008).
Choudhury, A., Sengupta, D., Aron, S. & Ramsay, M. in Africa, the Cradle of Human Diversity (eds Fortes-Lima, C. et al.) 257–304 https://doi.org/10.1163/9789004500228_011 (Brill, 2021).
Gurdasani, D. et al. Uganda Genome Resource enables insights into population history and genomic discovery in africa. Cell 179, 984–1002 (2019).
Asiki, G. et al. The general population cohort in rural south-western Uganda: a platform for communicable and non-communicable disease studies. Int. J. Epidemiol. 42, 129–141 (2013).
Fatumo, S. et al. Metabolic traits and stroke risk in individuals of African ancestry: Mendelian randomization analysis. Stroke 52, 2680–2684 (2021).
Boua, P. R. et al. Novel and known gene–smoking interactions with cIMT identified as potential drivers for atherosclerosis risk in West-African populations of the AWI-Gen Study. Front. Genet. 10, 1354 (2019).
Dlamini, S. N. et al. Associations between CYP17A1 and SERPINA6/A1 polymorphisms, and cardiometabolic risk factors in Black South Africans. Front. Genet. 12, 687335 (2021).
Gómez-Olivé, F. X. et al. Regional and sex differences in the prevalence and awareness of hypertension: an H3Africa AWI-Gen Study across 6 sites in sub-Saharan Africa. Glob. Heart 12, 81–90 (2017).
Nonterah, E. A. et al. Classical cardiovascular risk factors and HIV are associated with carotid intima-media thickness in adults from sub-Saharan Africa: findings from H3Africa AWI-Gen Study. J. Am. Heart Assoc. 8, e011506 (2019).
Sengupta, D. et al. Genetic substructure and complex demographic history of South African Bantu speakers. Nat. Commun. 12, 2080 (2021).
Aron, S. et al. The development of a sustainable bioinformatics training environment within the H3Africa bioinformatics network (H3ABioNet). Front. Educ. 6, 356 (2021).
Acharya, A., Schrauwen, I. & Leal, S. M. Identification of autosomal recessive nonsyndromic hearing impairment genes through the study of consanguineous and non-consanguineous families: past, present, and future. Hum. Genet. https://doi.org/10.1007/s00439-021-02309-9 (2021).
Harripaul, R. et al. Mapping autosomal recessive intellectual disability: combined microarray and exome sequencing identifies 26 novel candidate genes in 192 consanguineous families. Mol. Psychiatry 23, 973–984 (2018).
Khan, N. M. et al. Updates on clinical and genetic heterogeneity of ASPM in 12 autosomal recessive primary microcephaly families in Pakistani population. Front. Pediatr. 9, 695133 (2021).
Khan, A. A. et al. p.arg102ser is a common Pde6a mutation causing autosomal recessive retinitis pigmentosa in Pakistani families. J. Pak. Med. Assoc. 71, 816–821 (2021).
Manolio, T. A. Using the data we have: improving diversity in genomic research. Am. J. Hum. Genet. 105, 233–236 (2019).
Knight, H. M. et al. Homozygosity mapping in a family presenting with schizophrenia, epilepsy and hearing impairment. Eur. J. Hum. Genet. 16, 750–758 (2008).
Hampshire, D. J. et al. MORM syndrome (mental retardation, truncal obesity, retinal dystrophy and micropenis), a new autosomal recessive disorder, links to 9q34. Eur. J. Hum. Genet. 14, 543–548 (2006).
Atkinson, E. G. et al. Tractor uses local ancestry to enable the inclusion of admixed individuals in GWAS and to boost power. Nat. Genet. 53, 195–204 (2021).
Elsum, I. et al. Inclusion of indigenous Australians in biobanks: a step to reducing inequity in health care. Med. J. Aust. 211, 7–9 (2019).
Kowal, E. & Anderson, I. Genetic research in Aboriginal and Torres Strait Islander communities: continuing the conversation (Lowitja Institute, 2012).
Thomson, R. J. et al. New genetic loci associated with chronic kidney disease in an indigenous australian population. Front. Genet. 10, 330 (2019).
Gaskell, G. et al. Publics and biobanks: pan-European diversity and the challenge of responsible innovation. Eur. J. Hum. Genet. 21, 14–20 (2013).
Klarin, D. et al. Genetics of blood lipids among ~300,000 multi-ethnic participants of the Million Veteran Program. Nat. Genet. 50, 1514–1523 (2018).
A.R.M. has consulted for 23andMe and Illumina, and has received speaker fees from Genentech, Pfizer, and Illumina. All other authors declare no competing interests.
Peer review information
Nature Medicine thanks Ambroise Wonkam and the other, anonymous, reviewer(s) for their contribution to the peer review of this work. Karen O’Leary was the primary editor on this article and managed its editorial process and peer review in collaboration with the rest of the editorial team.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Fatumo, S., Chikowore, T., Choudhury, A. et al. A roadmap to increase diversity in genomic studies. Nat Med 28, 243–250 (2022). https://doi.org/10.1038/s41591-021-01672-4
Nature Medicine (2022)
Nature Reviews Genetics (2022)
A comprehensive genomic reporting structure for communicating all clinically significant primary and secondary findings
Human Genetics (2022)
Increasing diversity in genomics requires investment in equitable partnerships and capacity building
Nature Genetics (2022)